Survival outcome by early chemoradiation therapy salvage or early surgical salvage for the treatment of hypopharyngeal cancer

Otolaryngology - Head and Neck Surgery

Volumn 137, Issue 5, 2007, Pages 711-716

  Tsou, Yung An ^a   Lin, Meng Hung ^a   Hua, Chun Hung ^a   Tseng, Hsien Chang ^a   Chen, Shang Wen ^a   Yang, Shih Neng ^a   Liang, Ji An ^a   Tsai, Ming Hsui ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPOPHARYNX CANCER; LARYNGECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; OUTCOME ASSESSMENT; PLASTIC SURGERY; POSTOPERATIVE CARE; RADIATION DOSE; RETROSPECTIVE STUDY; SALVAGE THERAPY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE;

EID: 35448978318     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2007.07.022     Document Type: Article

References (12)

1. Hoffman H.T., Karnell L.H., Shah J.P., et al. Hypopharyngeal cancer patient care evaluation. Laryngoscope 107 (1997) 1005-1017
2. Tsou Y.A., Hua J.H., Lin M.H., et al. Analysis of prognostic factors of chemoradiation therapy for advanced hypopharyngeal cancer-does tumor volume correlate with central necrosis and tumor pathology?. ORL J Otorhinolaryngol Relat Spec 68 4 (2006) 206-212
3. Chen S.W., Yang S.N., Liang J.A., et al. Value of computed tomography-based tumor volume as a predictor of outcomes in hypopharyngeal cancer after treatment with definitive radiotherapy. Laryngoscope 116 11 (2006) 2012-2017
4. Hoffman H.T., Porter K., Karnell L.H., et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 116 9 Pt 2 Suppl 111 (2006) 1-13
5. Hoffman H.T., Karnell L.H., Funk G.F., et al. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 124 (1998) 951-962
6. Whalberg P.C., Andersson H., Björklund A.T., et al. Carcinoma of the hypopharynx: analysis of incidence and survival in Sweden over a 30-year period. Head Neck 20 (1998) 714-719
7. Zelefsky M.J., Kraus D.H., Pfister D.G., et al. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer. Head Neck 18 5 (1996) 405-411
8. Enepekides D.J. Concurrent chemoradiotherapy as the most appropriate treatment for most T3 laryngeal carcinomas. Arch Otolaryngol Head Neck Surg 131 (2005) 815-818
9. Slotman B.J., Kralendonk J.H., Snow G.B., et al. Surgery and postoperative radiotherapy and radiotherapy alone in T3-T4 cancers of the pyriform sinus: treatment results and patterns of failure. Acta Oncol 33 1 (1994) 55-60
10. Lefebvre J.L., Chevalier D., Luboinski B., et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88 13 (1996) 890-899
11. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. [No authors listed]. N Engl J Med 324 24 (1991) 1685-1690
12. Zelefsky M.J., Kraus D.H., Pfister D.G., et al. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer. Head Neck 18 5 (1996) 405-411